Experimenting with the Consumer: The Mass Testing of Risky Products on the American Public
Autor Marshall S. Shapoen Limba Engleză Hardback – 30 dec 2008
Through a diverse selection of dramatic case studies, Shapo lays bare the incentives of companies and entrepreneurial scientists to fake or obscure experimental data before and after government approval; the fights between interested and disinterested scientists over data; the fights between scientists and doctors over patient rights; the campaigns of activists against government agencies to release experimental drugs; the impact of the journalistic and promotional media on public knowledge and perception of product risk; and the marketing tricks that manufacturers use to harness sexual desire to product launches and to shape the prescription choices of physicians.
Preț: 294.88 lei
Preț vechi: 377.51 lei
-22%
Puncte Express: 442
Preț estimativ în valută:
52.17€ • 60.65$ • 45.22£
52.17€ • 60.65$ • 45.22£
Carte tipărită la comandă
Livrare economică 04-18 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780313365287
ISBN-10: 0313365288
Pagini: 304
Dimensiuni: 156 x 235 x 30 mm
Greutate: 0.45 kg
Editura: Bloomsbury Publishing
Colecția Praeger
Locul publicării:New York, United States
ISBN-10: 0313365288
Pagini: 304
Dimensiuni: 156 x 235 x 30 mm
Greutate: 0.45 kg
Editura: Bloomsbury Publishing
Colecția Praeger
Locul publicării:New York, United States
Cuprins
INTRODUCTION
Chapter One: EXPERIMENTATION: A SURVEY AT TRENCH LEVEL
Chapter Two: HIV/AIDS DRUGS: SPEEDING UP SCIENCE, UNDER
POLITICAL PRESSURE
Chapter Three: BREAST IMPLANTS: A PARABLE OF LAWS
RESPONSE TO IMPROVEMENTS ON NATURE
Chapter Four: TREATING THYSELFFOR MEN ONLY: VIAGRA
Chapter Five: ESTROGENSA GATHERING OF DATA, A
G
ATHERING STORM
Chapter Six: ESTROGENSTHE STORM BREAKS; A STRUGGLE
OF MEDICINE, LAW, AND POLITICS
Chapter Seven: EXPERIMENTS AT THE BILLION LEVEL
:NANOTECHNOLOGY
CONCLUSION
Chapter One: EXPERIMENTATION: A SURVEY AT TRENCH LEVEL
Chapter Two: HIV/AIDS DRUGS: SPEEDING UP SCIENCE, UNDER
POLITICAL PRESSURE
Chapter Three: BREAST IMPLANTS: A PARABLE OF LAWS
RESPONSE TO IMPROVEMENTS ON NATURE
Chapter Four: TREATING THYSELFFOR MEN ONLY: VIAGRA
Chapter Five: ESTROGENSA GATHERING OF DATA, A
G
ATHERING STORM
Chapter Six: ESTROGENSTHE STORM BREAKS; A STRUGGLE
OF MEDICINE, LAW, AND POLITICS
Chapter Seven: EXPERIMENTS AT THE BILLION LEVEL
:NANOTECHNOLOGY
CONCLUSION
Recenzii
HIV/AIDS drugs, breast implants, Viagra, estrogen, and nanotechnology are the examples Shapo (law, Northwestern U.) describes in detail, but he selected them from a great number of cases in which corporations profited by selling products that they knew were risky but that consumers did not. He concludes with advice for consumers and suggestions for policy changes.
Recommended. All readership levels.
I would recommend Experimenting with the Consumer to members of both the plaintiff bar and the public. As Shapo states, we should not be afraid after reading the revelations in this book; rather, we should all be alittle more sensible.
The book is extremely well referenced and scholarly. The author clearly and faithfully shows the tremendous pressure and expectations that the public can bring to federal agencies and manufacturers for treatments ranging from life threatening diseases (HIV/AIDS) to those that improve quality of life (Viagra, Premarin, Prempro). . . . Although the title of this book is one designed to attract attention, inside is a deep and thoughtful discussion of the systems in place-- regulatory, legal, scientific, and ethical--that balance the risks and benefits of products for the American public in an ongoing, dynamic way.
Recommended. All readership levels.
I would recommend Experimenting with the Consumer to members of both the plaintiff bar and the public. As Shapo states, we should not be afraid after reading the revelations in this book; rather, we should all be alittle more sensible.
The book is extremely well referenced and scholarly. The author clearly and faithfully shows the tremendous pressure and expectations that the public can bring to federal agencies and manufacturers for treatments ranging from life threatening diseases (HIV/AIDS) to those that improve quality of life (Viagra, Premarin, Prempro). . . . Although the title of this book is one designed to attract attention, inside is a deep and thoughtful discussion of the systems in place-- regulatory, legal, scientific, and ethical--that balance the risks and benefits of products for the American public in an ongoing, dynamic way.